Terms: = Lymphoma AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Diagnosis
17 results:
1. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Platzbecker U; Della Porta MG; Santini V; Zeidan AM; Komrokji RS; Shortt J; Valcarcel D; Jonasova A; Dimicoli-Salazar S; Tiong IS; Lin CC; Li J; Zhang J; Giuseppi AC; Kreitz S; Pozharskaya V; Keeperman KL; Rose S; Shetty JK; Hayati S; Vodala S; Prebet T; Degulys A; Paolini S; Cluzeau T; Fenaux P; Garcia-Manero G
Lancet; 2023 Jul; 402(10399):373-385. PubMed ID: 37311468
[TBL] [Abstract] [Full Text] [Related]
3. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Larkin KT; Nicolet D; Kelly BJ; Mrózek K; LaHaye S; Miller KE; Wijeratne S; Wheeler G; Kohlschmidt J; Blachly JS; Mims AS; Walker CJ; Oakes CC; Orwick S; Boateng I; Buss J; Heyrosa A; Desai H; Carroll AJ; Blum W; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Stone RM; Paskett ED; Byrd JC; Mardis ER; Eisfeld AK
Blood Adv; 2022 Oct; 6(19):5570-5581. PubMed ID: 35788257
[TBL] [Abstract] [Full Text] [Related]
4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
[TBL] [Abstract] [Full Text] [Related]
6. Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients.
Ou JY; Hanson HA; Ramsay JM; Kaddas HK; Pope CA; Leiser CL; VanDerslice J; Kirchhoff AC
Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):1929-1939. PubMed ID: 32404444
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-related transcription factor regulatory networks in human colorectal cancer.
Hao S; Huo S; Du Z; Yang Q; Ren M; Liu S; Liu T; Zhang G
Medicine (Baltimore); 2019 Apr; 98(15):e15158. PubMed ID: 30985693
[TBL] [Abstract] [Full Text] [Related]
8. Wilms Tumor 1 Expression at diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
[TBL] [Abstract] [Full Text] [Related]
9. Emerging molecular predictive and prognostic factors in acute myeloid leukemia.
McCurdy SR; Levis MJ
Leuk Lymphoma; 2018 Sep; 59(9):2021-2039. PubMed ID: 29095060
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract] [Full Text] [Related]
11. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract] [Full Text] [Related]
12. IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia.
Jeffries SJ; Jones L; Harrison CJ; Russell LJ
Haematologica; 2014 Aug; 99(8):1334-42. PubMed ID: 24816234
[TBL] [Abstract] [Full Text] [Related]
13. CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.
Slamova L; Starkova J; Fronkova E; Zaliova M; Reznickova L; van Delft FW; Vodickova E; Volejnikova J; Zemanova Z; Polgarova K; Cario G; Figueroa M; Kalina T; Fiser K; Bourquin JP; Bornhauser B; Dworzak M; Zuna J; Trka J; Stary J; Hrusak O; Mejstrikova E
Leukemia; 2014 Mar; 28(3):609-20. PubMed ID: 24270736
[TBL] [Abstract] [Full Text] [Related]
14. Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia.
Yang WC; Lin PM; Yang MY; Liu YC; Chang CS; Chou WC; Hsu JF; Huang CT; Cho SF; Yu WH; Lin SF
Leuk Lymphoma; 2013 Aug; 54(8):1614-25. PubMed ID: 23150981
[TBL] [Abstract] [Full Text] [Related]
15. A comparison of digitized frozen section and smear preparations for intraoperative neurotelepathology.
Gould PV; Saikali S
Anal Cell Pathol (Amst); 2012; 35(2):85-91. PubMed ID: 22297471
[TBL] [Abstract] [Full Text] [Related]
16. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
[TBL] [Abstract] [Full Text] [Related]
17. A controversial issue: could a watch-and-wait policy for patients with non-Hodgkin's lymphoma clinical stage I or IE with no lymphoma left following diagnostic surgery be justified? Results of a single centre study.
Jelić S; Frim O; Gligorijević G; Gavrilović D; Manojlović N; Jovanović V; Oprić M
Hematol Oncol; 1997 May; 15(2):53-61. PubMed ID: 9375030
[TBL] [Abstract] [Full Text] [Related]
